Sign in

CIK 0001855175 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Contineum Therapeutics, Inc.

Sign in to watch
Ticker
CTNM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
271467257
Phone
(858) 333-5280
Business address
3565 GENERAL ATOMICS COURT, SUITE 200, SAN DIEGO, CA, 92121
  1. 8-K Event Results of operations
  2. SCHEDULE 13G Stake Statement of Beneficial Ownership
  3. 4 Option exercise CMO & Sr VP, Clinical Dev. acquired 12,800 shares (option exercise)
  4. 10-Q Report Quarterly Report
  5. 8-K/A Event Results of operations · Regulation FD disclosure
  6. 8-K Event Results of operations
  7. 4 Derivatives Options or other derivatives
  8. 3 Insider Initial Statement of Ownership
  9. 8-K Event Executive or director change
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 8-K Event Executive or director change
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 8 of 11 · 202 filings